Kazia Therapeutics (KZIA) Cash from Operations (2019 - 2022)

Name: Kazia Therapeutics (KZIA) Cash from Operations (2019 - 2022) | Business Quant
Creator: Business Quant

Kazia Therapeutics (KZIA) posted Cash from Operations of 5785831.24 for Q4 2022, up 35.48% on a QoQ basis from 8968061.66 in Q4 2020.

Kazia Therapeutics (KZIA) has 3 years of Cash from Operations data on file, last reported at 5785831.24 in Q4 2022.

In Q4 2022, Cash from Operations changed N/A year-over-year to 5785831.24; the TTM figure through Dec 2022 stood at 31060237.78 (changed N/A YoY), while the FY2025 annual figure was 8503672.07, down 34.68% from the prior year.
Cash from Operations improved to 5785831.24 in Q4 2022, from 8968061.66 in the prior quarter.
Across five years, Cash from Operations topped out at 1869344.88 in Q4 2019 and bottomed at 8968061.66 in Q4 2020.
A 3-year average of 5541079.26 and a median of 5785831.24 in 2022 frame the typical range for Cash from Operations.
The widest YoY moves for Cash from Operations: up 379.74% in 2020, down 379.74% in 2020.
Year by year, Cash from Operations stood at 1869344.88 in 2019, then sank by 379.74% to 8968061.66 in 2020, then soared by 35.48% to 5785831.24 in 2022.
The last three Cash from Operations figures came in at 5785831.24 (Q4 2022), 8968061.66 (Q4 2020), and 1869344.88 (Q4 2019), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Operations (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-1.67 Mn
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-12.20 Mn
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-2.49 Mn
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	1.43 Bn
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	1.08 Bn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	70.50 Mn
10	Kazia Therapeutics	1.55 Bn	1.55 Bn	-	-

Download Data 🔒